Login

Sam Farres, M.D. Vascular Surgeon, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

All About Thoracic Outlet Syndrome (TOS): Overview

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Anatara Lifesciences transitions gut health focus from animals to humans - Steve Lydeamore, CEO, Anatara Lifesciences Ltd
00:10:00
Alexandre Guerrero on Eletromidia's Growth, Globo Partnership, and Future Prospects | Alexandre Guerrero , CEO , Eletromidia SA.
00:10:00
Why Early Health and Wealth Planning is Crucial for a Stress-Free Retirement
00:10:00
I'm Still Waiting For My Big Break|Talia Goldberg,Partner,Bessemer Venture Partners
00:10:00
2023 Rule Symposium Preview with David Cole, CEO of EMX Royalty Corp
00:10:00
"Expanding Opportunities in Commercial Lending: Dillon Freeman Joins LBC Capital’s San Diego Branch | Dillon Freeman - Managing Partner, LBC Capital"
00:10:00
Managing a Football Club: Challenges and Lessons from José E. Feliciano and Isabelle Scemama | José E. Feliciano, CEO, Clearlake Capital.
00:10:00
HEIDELBERG CEO Discusses Innovation at drupa 2024 | Dr. Ludwin Monz. - CEO of Heidelberger Druckmaschinen
00:10:00
Andrew Jacobson, CIO of Axiom Investors, discusses innovative strategies for investing ahead of market trends.
00:10:00
Setting Boundaries with Kyle Moore, CFP | Kyle Moore - FOUNDER, FINANCIAL PLANNER of Quarry Hill Advisors
00:10:00
Monix Resource's Larry Page Discusses Company Overview, Expertise, and Successful Mining Ventures
00:10:00
In-Depth Conversation with Supriya Lifescience MD Satish Wagh and Director Saloni Wagh: The Journey, Legacy, and Future Vision | Saloni Wagh, Director, Supriya Lifescience Limited.

© 2026 Nehu